• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the Week.消融以减少房颤负担并改善结局:JACC 本周综述专题。
J Am Coll Cardiol. 2023 Sep 5;82(10):1039-1050. doi: 10.1016/j.jacc.2023.06.029.
2
Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review.导管消融治疗心房颤动优于药物治疗:一项专题综述。
Ann Med. 2021 Dec;53(1):551-557. doi: 10.1080/07853890.2021.1905873.
3
2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.2-羟苯乙胺(2-HOBA)预防导管消融后心房颤动早期复发:一项包括使用可穿戴设备检测 AF 的随机对照试验方案。
Trials. 2021 Aug 28;22(1):576. doi: 10.1186/s13063-021-05553-6.
4
Advanced electrophysiologic mapping systems: an evidence-based analysis.先进的电生理标测系统:基于证据的分析
Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.
5
Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines.心力衰竭中心房颤动的导管消融:从证据到指南。
Curr Heart Fail Rep. 2021 Jun;18(3):153-162. doi: 10.1007/s11897-021-00508-z. Epub 2021 Apr 4.
6
Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial.导管消融与胸腔镜手术消融治疗长期持续性心房颤动(CASA-AF):一项随机对照试验的研究方案
Trials. 2018 Feb 20;19(1):117. doi: 10.1186/s13063-018-2487-9.
7
Atrial fibrillation ablation.心房颤动消融术
Rev Esp Cardiol (Engl Ed). 2012 Jun;65(6):560-9. doi: 10.1016/j.recesp.2011.12.023. Epub 2012 Apr 26.
8
Catheter Ablation Versus Medication in Atrial Fibrillation and Systolic Dysfunction: Late Outcomes of CAMERA-MRI Study.导管消融与药物治疗在心房颤动伴收缩功能障碍患者中的疗效比较:CAMERA-MRI 研究的长期随访结果。
JACC Clin Electrophysiol. 2020 Dec 14;6(13):1721-1731. doi: 10.1016/j.jacep.2020.08.019. Epub 2020 Oct 28.
9
Does catheter ablation for atrial fibrillation increase or reduce neurological insult?房颤导管消融术是否增加或减少神经损伤?
Curr Opin Cardiol. 2012 Jan;27(1):36-40. doi: 10.1097/HCO.0b013e32834d846a.
10
Ablation strategies for atrial fibrillation.心房颤动的消融策略
Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1091-101. doi: 10.1586/erc.09.96.

引用本文的文献

1
Atrial fibrillation burden and symptom, quality of life, and healthcare resource utilization after cryoballoon ablation in persistent atrial fibrillation.持续性心房颤动冷冻球囊消融术后的心房颤动负荷、症状、生活质量及医疗资源利用情况
Europace. 2025 Aug 4;27(8). doi: 10.1093/europace/euaf150.
2
Catheter Ablation vs Drug Therapy in Patients With Atrial Fibrillation and Nonmodifiable Recurrence Risk Factors: A Secondary Analysis of the CABANA Randomized Clinical Trial.心房颤动合并不可改变复发风险因素患者的导管消融与药物治疗:CABANA随机临床试验的二次分析
JAMA Netw Open. 2025 Aug 1;8(8):e2528124. doi: 10.1001/jamanetworkopen.2025.28124.
3
Wearable Devices for Quantifying Atrial Fibrillation Burden: A Systematic Review and Bayesian Meta-Analysis.用于量化房颤负荷的可穿戴设备:系统评价与贝叶斯Meta分析
J Cardiovasc Dev Dis. 2025 Mar 30;12(4):122. doi: 10.3390/jcdd12040122.
4
Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation.心房颤动患者消融术后复发模式及不良心血管结局
J Am Heart Assoc. 2025 May 6;14(9):e038832. doi: 10.1161/JAHA.124.038832. Epub 2025 Apr 17.
5
Association of Atrial Fibrillation Burden With Cardiovascular Outcomes in New-Onset Atrial Fibrillation Complicating Myocardial Infarction.新发房颤合并心肌梗死时房颤负荷与心血管结局的关联
J Am Heart Assoc. 2025 May 20;14(10):e039547. doi: 10.1161/JAHA.124.039547. Epub 2025 Apr 16.
6
Clinical Utility of the 4S-AF Scheme in Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation.4S-AF方案在预测射频导管消融术后房颤复发中的临床应用价值
Rev Cardiovasc Med. 2025 Mar 14;26(3):26318. doi: 10.31083/RCM26318. eCollection 2025 Mar.
7
Catheter Ablation in Atrial Fibrillation: Recent Advances.心房颤动的导管消融:最新进展
J Clin Med. 2024 Dec 17;13(24):7700. doi: 10.3390/jcm13247700.
8
Machine Learning-Based Identification of High-Risk Patterns in Atrial Fibrillation Ablation Outcomes.基于机器学习的房颤消融结果高风险模式识别
medRxiv. 2024 Dec 1:2024.11.27.24318097. doi: 10.1101/2024.11.27.24318097.
9
Associations of lipids and lipid-modifying drug target genes with atrial fibrillation risk based on genomic data.基于基因组数据的脂质和脂质修饰药物靶点基因与心房颤动风险的相关性研究。
Lipids Health Dis. 2024 Jun 8;23(1):175. doi: 10.1186/s12944-024-02163-4.
10
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.心房颤动患者的更长更好的生命:第 9 届 AFNET/EHRA 共识会议。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae070.

本文引用的文献

1
Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.房颤负担的医疗保健利用和生活质量:CIRCA-DOSE 研究。
Eur Heart J. 2023 Mar 1;44(9):765-776. doi: 10.1093/eurheartj/ehac692.
2
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.冷冻消融或药物治疗后心房颤动的进展。
N Engl J Med. 2023 Jan 12;388(2):105-116. doi: 10.1056/NEJMoa2212540. Epub 2022 Nov 7.
3
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial.实现窦律可改善房颤早期节律控制治疗的预后:EAST-AFNET 4 试验。
Eur Heart J. 2022 Oct 21;43(40):4127-4144. doi: 10.1093/eurheartj/ehac471.
4
Reflections on the usefulness of today's atrial fibrillation ablation procedure endpoints and patient-reported outcomes.对当今心房颤动消融术终点和患者报告结局的实用性的思考。
Europace. 2022 Jun 6;24(Suppl 2):ii29-ii43. doi: 10.1093/europace/euab318.
5
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.随机消融节律控制与心率控制治疗心力衰竭伴心房颤动患者的比较:来自 RAFT-AF 试验的结果。
Circulation. 2022 Jun 7;145(23):1693-1704. doi: 10.1161/CIRCULATIONAHA.121.057095. Epub 2022 Mar 22.
6
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.心律失常负担与伴有阵发性心房颤动和心脏植入式电子设备患者心血管结局的风险。
Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010304. doi: 10.1161/CIRCEP.121.010304. Epub 2022 Jan 28.
7
Influence of Monitoring Strategy on Assessment of Ablation Success and Postablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.监测策略对消融成功评估和消融后心房颤动负荷评估的影响:对实践和临床试验设计的意义。
Circulation. 2022 Jan 4;145(1):21-30. doi: 10.1161/CIRCULATIONAHA.121.056109. Epub 2021 Nov 24.
8
Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.心房颤动负荷与心房颤动消融后健康相关生活质量的关系:冷冻球囊与接触力指导心房颤动消融(CIRCA-DOSE)随机临床试验的亚研究。
JAMA Cardiol. 2021 Nov 1;6(11):1324-1328. doi: 10.1001/jamacardio.2021.3063.
9
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.消融与药物治疗在少数民族人群中的心房颤动。
J Am Coll Cardiol. 2021 Jul 13;78(2):126-138. doi: 10.1016/j.jacc.2021.04.092.
10
Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation.阵发性与持续性心房颤动患者的导管消融治疗及医疗利用和成本
Heart Rhythm O2. 2020 Dec 15;2(1):28-36. doi: 10.1016/j.hroo.2020.12.017. eCollection 2021 Feb.

消融以减少房颤负担并改善结局:JACC 本周综述专题。

Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the Week.

机构信息

Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Québec, Canada.

出版信息

J Am Coll Cardiol. 2023 Sep 5;82(10):1039-1050. doi: 10.1016/j.jacc.2023.06.029.

DOI:10.1016/j.jacc.2023.06.029
PMID:37648353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11103629/
Abstract

Atrial fibrillation is the most common atrial arrhythmia and accounts for a significant burden of cardiovascular disease globally. With advances in implanted and wearable cardiac monitoring technology, it is now possible to readily and accurately quantify an individual's time spent in atrial fibrillation. This review summarizes the relationship between atrial fibrillation burden and adverse cardiovascular and cerebrovascular outcomes and discusses the role of catheter ablation to mitigate the morbidity and mortality associated with greater burden of atrial fibrillation.

摘要

心房颤动是最常见的房性心律失常,在全球范围内给心血管疾病带来了巨大负担。随着植入式和可穿戴式心脏监测技术的进步,现在可以方便、准确地量化个体心房颤动的时间。本文综述了心房颤动负荷与不良心血管和脑血管结局之间的关系,并讨论了导管消融在减轻与心房颤动负荷增加相关的发病率和死亡率方面的作用。